Lymphocyte subset modulation

Lymphocyte subset modulation refers to interventions that alter the balance, number, function, or activity of specific lymphocyte subpopulations (such as T cells, B cells, and NK cells) to achieve a desired therapeutic goal. This may be accomplished using drugs (immunosuppressants, antibodies, siRNAs, etc.), cell therapy, or biological agents that specifically target surface markers or signaling pathways of lymphocyte subsets. Modulation of these populations is widely used in the treatment of cancer, autoimmune conditions, transplantation, and infectious diseases, but does not represent a single defined molecular target—rather, it is a general strategy in immunotherapy that encompasses diverse targets and mechanisms. This entry is unsuitable as a "target molecule/receptor" due to its conceptual, not molecular, nature; no single molecule, abbreviation, or molecular family can be provided.

Other names

Lymphocyte modulationLymphocyte subset manipulationImmune cell subset modulationImmunomodulation of lymphocyte subsets

Inhibition or activation of specific lymphocyte subsets (e.g., CD4+, CD8+ T cells, B cells) through direct binding, signaling modulation, gene silencing, or other immunomodulatory approaches; Targeted depletion (e.g., anti-CD20 agents for B cells); Metabolic modulation; Cytokine modulation; Cell proliferation and apoptosis modulation